Industry

Amniotic membrane transplantation a versatile tool

Healio Optometry2d ago1 min read

Amniotic membrane has been in clinical use in ophthalmology for more than half a century. The histological nature of the membrane has been used for various eye surface diseases, and indications have expanded.Amniotic membrane (AM) is the innermost layer of the placenta and consists of a thick basement membrane and an avascular stromal matrix. Since its first ophthalmic use in the 1940s and its reintroduction by Tseng and colleagues in the 1990s, amniotic membrane transplantation (AMT) has become an important tool in ocular surface reconstruction.AM is composed of five layers: epithelial

Read full article on Healio Optometry

AI Summary

Quick Take

Amniotic membrane transplantation (AMT) has evolved into a cornerstone of ocular surface reconstruction since its clinical reintroduction in the 1990s. Derived from the innermost layer of the placenta, this tissue provides a thick basement membrane and an avascular stromal matrix that serves as a versatile biological scaffold for treating a wide range of ocular surface diseases.

Why It Matters

For the modern anterior segment specialist, AM represents a unique bioactive tool that leverages the histological properties of placental tissue to promote healing. Its use has spanned over half a century, proving its reliability as a surgical and clinical intervention. Understanding its complex five-layer composition is essential for clinicians looking to expand their toolkit for managing complex surface pathologies and reconstruction cases.

Key Details

Amniotic membrane is the innermost layer of the placenta, characterized by a thick basement membrane and an avascular stromal matrix.
The tissue is histologically complex and composed of five distinct layers, including an epithelial layer.
While first used in ophthalmology in the 1940s, the modern application of AMT was popularized by Tseng and colleagues in the 1990s.
The membrane is primarily utilized as a versatile tool for ocular surface reconstruction and the management of various surface diseases.

Practice Implications

Clinicians should consider AMT as a primary option for ocular surface reconstruction, particularly when a biological scaffold is required to support healing. Its avascular nature and specific histological structure make it uniquely suited for complex surface diseases where traditional treatments may be insufficient.

Who's Affected

Cornea SpecialistsAnterior Segment SurgeonsComprehensive OphthalmologistsOptometrists managing ocular surface disease

Evidence StrengthStrong

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.